And so we moved into the era of SLNB for patients with clinically
negative axillas.
Axillary staging being a prime motivation for axillary surgery, used to
guide adjuvant therapy choices, rather than solely for disease control
Even so, recent St Gallen guidelines (2013) suggest that the total
number of nodes involved is less important than nodal status plus
tumour biology, so further weakening the drive towards completion
clearance
A Paradigm Shift…..